CRISPR Therapeutics AG (LON:0VRQ)
London
· Delayed Price · Currency is GBP · Price in USD 37.69
-0.65 (-1.71%)
At close: Apr 28, 2025
CRISPR Therapeutics AG Revenue
In the year 2024, CRISPR Therapeutics AG had annual revenue of $37.31M USD, down -89.95%. CRISPR Therapeutics AG had revenue of $35.69M in the quarter ending December 31, 2024, a decrease of -82.26%.
Revenue
$37.31M
Revenue Growth
-89.95%
P/S Ratio
81.98
Revenue / Employee
$94.95K
Employees
393
Market Cap
2.44B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 37.31M | -333.89M | -89.95% |
| Dec 31, 2023 | 371.21M | 370.01M | 30,885.48% |
| Dec 31, 2022 | 1.20M | -913.77M | -99.87% |
| Dec 31, 2021 | 914.96M | 914.24M | 127,154.94% |
| Dec 31, 2020 | 719.00K | -288.87M | -99.75% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| Shell | 227.10B |
| HSBC Holdings | 48.93B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| British American Tobacco p.l.c. | 25.87B |
| Rolls-Royce Holdings | 18.91B |